Integrated Emergency Medicine Specialists Joins Emergency Care Partners
Strategic Merger will Enable Integrated Emergency Medicine Specialists to Leverage Emergency Care Partner’s Resources for Emergency Department Services and Growth.
PENSACOLA, Fla., September 21, 2023 (Newswire.com)
–
Emergency Care Partners (“ECP”), a leading national physician-owned emergency medicine service provider, announced today the completion of a strategic merger with Integrated Emergency Medicine Specialists (“IEMS”). IEMS has served the Naples, FL, community since 2015, providing premier emergency department management services to its partner hospitals.
IEMS will continue a service-first approach to support its client emergency departments while leveraging ECP’s unique model of combining local physician equity partnerships and a differentiated clinical analytics platform focused on high-quality patient care.
ECP Chief Executive Officer, Bill Yarbrough, said, “We are very excited to welcome IEMS and their providers as a regional physician group practice of Emergency Care Partners. Their strong clinical leadership and reputation in the local community make them an ideal addition to our national group partnership of physician practices. We are excited to work with Dr. Brown to leverage our resources to deepen their relationships with key health system partners and continue to grow their local practice.
The ECP physician partnership model now serves 56 clinical locations, supported by a combined clinical workforce of more than 1,000 physicians and advanced practice providers, treating 1.4 million patients annually.
ECP is backed by financial sponsors Varsity Healthcare Partners (“VHP”) and Regal Healthcare Capital Partners (“Regal”).
“This partnership allows us to leverage ECP’s infrastructure and resources to continue to deliver the highest quality care and experiences to our patients and strengthen our health system partnerships in Southwest Florida,” said IEMS President, Dr. Hunter Brown, D.O.
Massumi + Consoli LLP and Morgan Lewis & Bockius LLP acted as legal advisers to ECP and VHP, while Dean Mead acted as legal advisors to IEMS.
About Emergency Care Partners
Headquartered in Pensacola, Florida, ECP is a leading provider of emergency medicine and emergency department management services for hospitals across the U.S., with current operations in Arizona, Florida, Illinois, Louisiana, Oklahoma, New York, North Carolina, and Texas. ECP sees 1.4 million patient visits annually across operations at 56 clinical programs, supported by a clinical workforce of 1,000+ physicians and advanced practice providers. ECP employs a differentiated model relative to other platforms in the emergency medicine space, highlighted by the ability to maintain ownership through its physician partnership model and the ability for regional/local groups to maintain their branding and clinical autonomy while still benefitting from ECP’s significant back-office infrastructure. This critical infrastructure includes support for revenue cycle, financial and operational reporting, recruiting, training, compliance, contracting, scheduling, and payroll, among other functions. ECP’s affiliated physician groups also have access to the national partnership’s proprietary analytics platform, which operatively interfaces in real time with each hospital’s IT platform to track and report daily key performance indicators (KPI) in the emergency room. These include throughput, capacity utilization, clinical quality metrics, and ancillary services reporting, which are used by ECP clinical and operational leaders and the hospitals themselves to drive quality service and outcomes and a consistent patient experience within each customer’s emergency department. For more information, please visit www.ecp.net.
About Integrated Emergency Medicine Specialists (“IEMS”).
Founded in October 2015 and headquartered in Naples, FL, IEMS is a leading provider of emergency department management services, focusing on process improvement and quality patient care. IEMS provides emergency department medical directorship and management services, including recruitment, credentialing, and qualifying for third-party billing contracts and requirements.
About Varsity Healthcare Partners
Varsity Healthcare Partners (VHP) is a lower middle-market private equity investment firm focused on partnering with founders, entrepreneurs, and management teams to build leading healthcare services companies. VHP’s unique tactical investment playbook and strong track record is complemented by VHP’s distinct organizational culture, emphasizing highly collaborative engagement, strong professional accountability, and a commitment to excellence in work product and team performance. For more information, please visit www.varsityhealthcarepartners.com.
About Regal Healthcare Capital Partners
Regal Healthcare Capital Partners (“Regal”) is a New York-based growth equity and buyout firm focused exclusively on lower-middle market healthcare services companies. Regal partners with leading-edge healthcare entrepreneurs in need of financial investment and strategic, operational, and managerial expertise. Regal and its co-founders, David Kim, M.D., and Jon Santemma, bring a unique combination of operational and transactional experience to healthcare services companies to help realize their growth potential. For more information, please visit www.regalhcp.com
Contact Information:
Kacie Hackel
National Marketing Manager
Original Source:
Integrated Emergency Medicine Specialists Joins Emergency Care Partners
Unboxed Training & Technology Receives LTEN Excellence Award for Learning Content
LTEN Excellence Awards Unboxed Wins Prestigious LTEN Excellence Award for Learning Content
RICHMOND, Va., September 21, 2023 (Newswire.com)
–
Unboxed …
AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy
The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today’s challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
AcCELLerate Forum
The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today’s challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
MILWAUKEE, September 21, 2023 (Newswire.com)
–
– AcCELLerate Forum, a partnership between Center for International Blood and Marrow Transplant Research (CIBMTR), the American Society for Transplantation and Cellular Therapy (ASTCT), and the National Marrow Donor Program (NMDP)/Be The Match, will bring key stakeholders together to identify ongoing needs and opportunities in cell and gene therapy for advocacy, measurement of value, impact, and sustainability. The Oct. 2-3, workshop at the Sheraton Pentagon City Hotel in Arlington, VA, and online will bring together providers, payers, government agencies, and industry members to define essential factors needed to create a sustainable cell and gene therapy ecosystem.
“CIBMTR is proud to co-sponsor this important forum that interests all key stakeholders across the ecosystem,” said Marcelo Pasquini, MD, MS, Senior Scientific Director, CIBMTR MCW. “Our established relationships with a global network of treatment centers and cell and gene therapy developers uniquely position CIBMTR to bring these experts together to identify the needs and opportunities to adapt to this rapidly evolving field.”
CIBMTR will join industry leaders, treatment-center partners, regulators, and other professionals to discuss the regulatory landscape for the approval of new products. The participants will focus on the perspectives of the payer and regulators, data acquisition and analysis, and center perspectives in defining outcomes for CAR-T cells. They will also discuss logistics for CAR-T, safety and toxicity, and the future directions and competing therapies. The forum will also include breakout sessions on the logistics of cell therapy delivery, efficacy, treatment decisions and sequencing, and manufacturing and logistics standardization in a moderator-led roundtable with attendee participation. Visit the event website to register.
Eligible members of the media are invited to attend AcCELLerate Forum in-person or online at no cost. Please contact Jennifer Kasowicz ([email protected]), Director of Marketing at ASTCT, at (312) 673-4970, to verify eligibility and receive the passcode.
About CIBMTR
The Center for International Blood and Marrow Transplant Research (CIBMTR) is a nonprofit research collaboration between the NMDP/Be The Match, in Minneapolis, and the Medical College of Wisconsin, in Milwaukee. CIBMTR collaborates with the global scientific community to increase survival and enrich the quality of life for patients. CIBMTR facilitates critical observational and interventional research through scientific and statistical expertise, a large network of centers, and a unique database of long-term clinical data for more than 635,000 people who have received hematopoietic cell transplantation and other cellular therapies. Learn more at cibmtr.org.
About ASTCT
The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 3,000 physicians, investigators, and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. For more information about ASTCT, visit www.astct.org and follow us on Twitter, @ASTCT.
About NMDP/Be The Match
The National Marrow Donor Program (NMDP)/Be The Match is the leading global partner working to save lives through cellular therapy. With 35 years of experience managing the most diverse registry of potential unrelated blood stem cell donors and cord blood units in the world, NMDP/Be The Match is a proven partner in providing cures to patients with life-threatening blood and marrow cancers and diseases. Through their global network, they connect centers and patients to their best cell therapy option—from blood stem cell transplant to a next-generation therapy—and collaborate with cell and gene therapy companies to support therapy development and delivery through Be The Match BioTherapies.
Contact Information:
Jennifer Kasowicz
ASTCT Marketing Director
(312) 673-4970
Original Source:
AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy
Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells
Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran
Total venture funding tops $50M to date
…
HealthAxis Earns Great Place to Work Certification
HealthAxis, a prominent provider of core administrative processing solutions and BPaaS capabilities to healthcare payers, risk-bearing providers, and third-party administrators, announced it has been Certified™ by Grea…
Peregrine Health Services to Present at Emergency Nursing 2023
Leading consultancy for emergency department and trauma center optimization brings its experience and expertise to the foremost conference for emergency department nurses.
…
Vituity Celebrates Expansion of Physician-Led Healthcare Services in Dallas
Physician-Owned Multispecialty Group Grows in Dallas with Wellness Studio, National Office, and Annual Conference
Vituity Vituity logo file
…
Staffing Industry Leader NEXTAFF Opens North Country, NH Healthcare Office
Owner brings over 25 years in healthcare experience to Healthcare Staffing Agency.
NEXTAFF of North Country Healthcare Staffing Agency
…
Interlace Health Joins MEDITECH Alliance Innovator Program to Deliver Leading eForm Solutions to Expanse Clients
The health IT vendor partnership extends Interlace Health’s forms automation and electronic signature capture capabilities to MEDITECH Expanse EHR customers
MEDITECH Alliance
Interlace Health is a MEDITECH Alliance Innovator Partner
ST. LOUIS, September 20, 2023 (Newswire.com)
–
As a member of the MEDITECH Alliance Innovator Program, Interlace Health delivers proven, successful, and interoperable forms automation, check printing, and eSignature solutions to health systems using MEDITECH Expanse.
Interlace Health works in conjunction with MEDITECH Expanse to enable paperless consenting. Providers can easily and efficiently collect eSignatures from patients and witnesses at the bedside, during clinic visits, and at registration. MEDITECH customers have transformed their eConsent, Patient Intake, Check Printing, and Forms-on-Demand processes with Interlace Health, in the acute, ambulatory, and post-acute care settings.
“We are happy to welcome Interlace to the Alliance,” said James Merlin, Chief Business Development Officer at MEDITECH. “We look forward to customers realizing the benefits of a standardized approach to delivering forms automation, check printing, and eSignature solutions through our partnership.”
MEDITECH Alliance is an ecosystem of healthcare technology companies that effectively collaborate with MEDITECH and complement, enhance, or extend MEDITECH Expanse. The MEDITECH Alliance Innovator Program is an invitation-only program consisting of MEDITECH partners with validated solution integration for specific use cases within Expanse. Innovator solutions are certified with MEDITECH’s technical and application teams. As a result, these solutions will be more deeply integrated in the MEDITECH EHR, with accelerated, seamless deployment based on standardized best practices and shared implementation guides.
As an Innovator, Interlace Health provides leading eForm, check printing, and eSignature solutions to MEDITECH Expanse customers.
“Our partnership and deep integration capabilities with MEDITECH have always been a key component to our success, as well as that of our shared 400+ hospital clients. As an Innovator in the MEDITECH Alliance, we look forward to helping MEDITECH Expanse organizations eliminate remaining paper processes to further drive cost and time savings, improve experiences, and ensure compliance,” said Allison Reichenbach, President at Interlace Health.
Interlace Health looks forward to presenting at MEDITECH LIVE September 20-22, in Foxborough, MA. Learn more about connecting with Interlace Health at MEDITECH LIVE: https://interlacehealth.com/meditech-live-2023/
About Interlace Health
Interlace Health (the next generation of FormFast) delivers forms automation and eSignature solutions that are more scalable and cost-effective than your EHR. For more than 30 years, Interlace Health has pioneered eForms, eSignature, and workflow technology.
By enabling seamless data capture and information exchange among providers, staff, and patients, Interlace Health solves many of healthcare’s central challenges through process transformation. The result for its clients is reduced costs, increased collections, uplifted patient experiences, improved operational efficiency, and enhanced support of an organization’s integration strategy. Interlace Health’s platform enables several solutions that are accessible by clinicians and patients inside and outside the walls of the healthcare system. These include Forms on Demand, Patient Intake, and eConsent. To learn more, visit www.interlacehealth.com.
Contact Information:
Lauren Ziegler
Director, Marketing Communications
314-677-3765
Original Source:
Interlace Health Joins MEDITECH Alliance Innovator Program to Deliver Leading eForm Solutions to Expanse Clients
Significant Court Decision Safeguards Professional Hospital Guaynabo’s Contractual Relationship With MSO of Puerto Rico Amidst Ongoing Arbitration Process
GUAYNABO, Puerto Rico, September 20, 2023 (Newswire.com)
–
Professional Hospital Guaynabo (PHG) issued the following statement in light of the recent ruling by Judge Alfonso Martínez Piovanetti of the Court of First Instance of Puerto Rico, ordering MSO of Puerto Rico, a subsidiary of Elevance Health, to uphold its Hospital Service Agreement (HSA) with PHG throughout the ongoing arbitration process.
“The Court’s decision to uphold the existing partnership between Professional Hospital Guaynabo and MSO of Puerto Rico not only guarantees that our patients will continue to benefit from world-class medical care provided by trusted physicians but also ensures network adequacy and compliance with CMS standards,” stated Administrator Giancarlo Valentín, PhD, MHSA.
Background:
PHG, situated in the Municipality of Guaynabo, serves as the municipality’s sole general hospital, catering to the needs of over 89,000 residents. Providing round-the-clock emergency room services, PHG annually serves 33,000 patients. The hospital achieved Hero Hospital status during both the COVID-19 pandemic and Hurricane Maria, known for its medical expertise in vascular diseases and the performance of cutting-edge surgeries, making it a healthcare cornerstone in Puerto Rico.
Contact Information:
Giancarlo Valentin